Try our beta test site
3671 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Recruiting Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
2 Recruiting Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition: Early Breast Cancer
Intervention: Other: Endocrine therapy interruption
3 Terminated Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
4 Active, not recruiting Predictors of Adjuvant Endocrine Therapy in Women With Breast Cancer
Condition: Breast Cancer Female
Intervention: Behavioral: No Intervention
5 Recruiting Sex Hormone Therapy and Mucosal Tissues
Condition: Hiv
Interventions: Procedure: Anoscopy with Rectal Tissue Sampling;   Procedure: Phlebotomy;   Procedure: Female Genital Tract Sampling;   Procedure: Semen Sampling
6 Active, not recruiting Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Condition: Female Breast Cancer
Intervention: Behavioral: Enhanced information about endocrine therapy
7 Completed Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: letrozole
8 Recruiting Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Tamoxifen;   Drug: Toremifene
9 Active, not recruiting Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Condition: Invasive Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrazole
10 Terminated 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab plus Pertuzumab;   Drug: Hormonal Therapy with Anastrozole and Fulvestrant;   Drug: Chemotherapy with Eribulin
11 Terminated Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Condition: Breast Cancer
Interventions: Procedure: Acupuncture;   Procedure: Sham acupuncture therapy
12 Completed Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy
Conditions: Weak; Pelvic Floor;   Weak; Muscle;   Urinary Incontinence
Intervention: Behavioral: pelvic floor muscle training
13 Not yet recruiting Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer
Condition: Breast Cancer Female
Intervention: Drug: Palbociclib
14 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
15 Completed Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Conditions: Hypercholesterolemia;   Postmenopause
Interventions: Drug: L-arginine;   Drug: Estrogen
16 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens
17 Completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: chemotherapy;   Drug: endocrine therapy;   Genetic: DNA methylation analysis;   Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
18 Active, not recruiting Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Letrozole
19 Recruiting Cognitive Sequelae of Adjuvant Endocrine Therapy for the Treatment of Breast Cancer in Older Women
Condition: Breast Cancer
Intervention: Other: Neuropsychological test battery
20 Completed Growth Hormone Treatment of Women With Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Growth Hormone;   Drug: Placebo;   Other: Healthy controls

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.